# PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and Vomiting

> **NCT03204279** · PHASE2 · COMPLETED · sponsor: **Helsinn Healthcare SA** · enrollment: 67 (actual)

## Conditions studied

- Chemotherapy-induced Nausea and Vomiting (CINV)

## Interventions

- **DRUG:** Netupitant
- **DRUG:** Palonosetron
- **DRUG:** Netupitant
- **DRUG:** Palonosetron

## Key facts

- **NCT ID:** NCT03204279
- **Lead sponsor:** Helsinn Healthcare SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-31
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-09-30
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03204279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03204279, "PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and Vomiting". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03204279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*